These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8893446)

  • 21. Hyperacute skin allograft rejection in presensitized rats is abrogated by malononitrilamides.
    Schorlemmer HU; Kurrle R
    Transplant Proc; 1998 Jun; 30(4):963-7. PubMed ID: 9636390
    [No Abstract]   [Full Text] [Related]  

  • 22. Saccharomyces cerevisiae MLF3/YNL074C gene, encoding a serine-rich protein of unknown function, determines the level of resistance to the novel immunosuppressive drug leflunomide.
    Fujimura HA
    Biochim Biophys Acta; 1998 Nov; 1442(2-3):415-8. PubMed ID: 9805003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunomodulatory effect of leflunomide in rat cardiac allotransplantation.
    D'Silva M; Candinas D; Achilleos O; Lee S; Antoniou E; DeRoover A; Germenis A; Stavropoulos C; Buckels J; Mayer D
    Transplantation; 1995 Sep; 60(5):430-7. PubMed ID: 7676489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of malononitriloamide analogs of leflunomide on whole blood lymphocyte stimulation in humans, rhesus macaques, cats, dogs, and rats.
    Gregory CR; Silva HT; Patz JD; Morris RE
    Transplant Proc; 1998 Jun; 30(4):1047-8. PubMed ID: 9636423
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of leflunomide and cyclosporine on myocutaneous allograft survival in the rat.
    Yeh LS; Gregory CR; Griffey SM; Lecouteur RA; Morris RE
    Transplantation; 1996 Sep; 62(6):861-3. PubMed ID: 8824490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide.
    Knight DA; Hejmanowski AQ; Dierksheide JE; Williams JW; Chong AS; Waldman WJ
    Transplantation; 2001 Jan; 71(1):170-4. PubMed ID: 11211189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of leflunomide and other immunosuppressive agents on T cell proliferation in vitro.
    Chong AS; Rezai K; Gebel HM; Finnegan A; Foster P; Xu X; Williams JW
    Transplantation; 1996 Jan; 61(1):140-5. PubMed ID: 8560553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppression with leflunomide and cyclosporine prevents pig-to-rat islet xenograft rejection.
    Wennberg L; Wallgren AC; Sundberg B; Rafael E; Zhu S; Liu J; Tibell A; Karlsson-Parra A; Groth CG; Korsgren O
    Transplant Proc; 1995 Dec; 27(6):3314-5. PubMed ID: 8539967
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular cloning of Saccharomyces cerevisiae MLF4/SSH4 gene which confers the immunosuppressant leflunomide resistance.
    Fujimura H
    Biochem Biophys Res Commun; 1998 May; 246(2):378-81. PubMed ID: 9610367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel mechanism of inhibition of cytomegalovirus by the experimental immunosuppressive agent leflunomide.
    Waldman WJ; Knight DA; Lurain NS; Miller DM; Sedmak DD; Williams JW; Chong AS
    Transplantation; 1999 Sep; 68(6):814-25. PubMed ID: 10515382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leflunomide. Arava, HWA 486, SU 101.
    Drugs R D; 1999 Jan; 1(1):87-91. PubMed ID: 10565997
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmacologically induced regression of chronic transplant rejection.
    Xiao F; Chong A; Shen J; Yang J; Short J; Foster P; Sankary H; Jensik S; Mital D; McChesney L
    Transplantation; 1995 Nov; 60(10):1065-72. PubMed ID: 7482709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production.
    Siemasko K; Chong AS; Jäck HM; Gong H; Williams JW; Finnegan A
    J Immunol; 1998 Feb; 160(4):1581-8. PubMed ID: 9469413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of experimental autoimmune neuritis by leflunomide.
    Korn T; Toyka K; Hartung HP; Jung S
    Brain; 2001 Sep; 124(Pt 9):1791-802. PubMed ID: 11522581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of B cell function by the immunosuppressive agent leflunomide.
    Siemasko KF; Chong AS; Williams JW; Bremer EG; Finnegan A
    Transplantation; 1996 Feb; 61(4):635-42. PubMed ID: 8610393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of leflunomide on T-independent xenoantibody formation in rats receiving hamster heart xenografts.
    Lin Y; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):952. PubMed ID: 8623477
    [No Abstract]   [Full Text] [Related]  

  • 37. As2 O3 combined with leflunomide prolongs heart xenograft survival via suppressing the response of Th1, Th2, and B cells in a rat model.
    Jiao ZX; Leng Y; Xia JJ; Wu HQ; Jin N; Fu JZ; Cheng LN; Wang JH; Ni SB; Qi ZQ
    Xenotransplantation; 2016 May; 23(3):237-48. PubMed ID: 27188662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2.
    Cao WW; Kao PN; Aoki Y; Xu JC; Shorthouse RA; Morris RE
    Transplant Proc; 1996 Dec; 28(6):3079-80. PubMed ID: 8962191
    [No Abstract]   [Full Text] [Related]  

  • 39. Suppression of natural xenophile antibodies with the novel immunomodulating drug leflunomide.
    Ulrichs K; Kaitschick J; Bartlett R; Müller-Ruchholtz W
    Transplant Proc; 1992 Apr; 24(2):718-9. PubMed ID: 1566498
    [No Abstract]   [Full Text] [Related]  

  • 40. Growth inhibition of Saccharomyces cerevisiae by the immunosuppressant leflunomide is due to the inhibition of uracil uptake via Fur4p.
    Fujimura H
    Mol Gen Genet; 1998 Oct; 260(1):102-7. PubMed ID: 9829833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.